Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2013 2
2014 1
2015 1
2021 1
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancer.
Kawada J, Saito T, Kurokawa Y, Kawabata R, Takeno A, Takeoka T, Nose Y, Wada H, Eguchi H, Doki Y; Osaka University Clinical Research Group for Gastroenterological Study. Kawada J, et al. Ann Gastroenterol Surg. 2023 Nov 20;8(2):243-250. doi: 10.1002/ags3.12757. eCollection 2024 Mar. Ann Gastroenterol Surg. 2023. PMID: 38455491 Free PMC article.
Long-term outcomes after prophylactic bursectomy in patients with resectable gastric cancer: Final analysis of a multicenter randomized controlled trial.
Hirao M, Kurokawa Y, Fujita J, Imamura H, Fujiwara Y, Kimura Y, Takiguchi S, Mori M, Doki Y; Osaka University Clinical Research Group for Gastroenterological Study. Hirao M, et al. Surgery. 2015 Jun;157(6):1099-105. doi: 10.1016/j.surg.2014.12.024. Epub 2015 Feb 20. Surgery. 2015. PMID: 25704429 Clinical Trial.
Oral nutritional supplements versus a regular diet alone for body weight loss after gastrectomy: a phase 3, multicenter, open-label randomized controlled trial.
Miyazaki Y, Omori T, Fujitani K, Fujita J, Kawabata R, Imamura H, Okada K, Moon JH, Hirao M, Matsuyama J, Saito T, Takahashi T, Kurokawa Y, Yamasaki M, Takiguchi S, Mori M, Doki Y; Osaka University Clinical Research Group for Gastroenterological Study. Miyazaki Y, et al. Gastric Cancer. 2021 Sep;24(5):1150-1159. doi: 10.1007/s10120-021-01188-3. Epub 2021 Apr 9. Gastric Cancer. 2021. PMID: 33835329 Clinical Trial.
Impact of reconstruction method on visceral fat change after distal gastrectomy: results from a randomized controlled trial comparing Billroth I reconstruction and roux-en-Y reconstruction.
Tanaka K, Takiguchi S, Miyashiro I, Hirao M, Yamamoto K, Imamura H, Yano M, Mori M, Doki Y; Osaka University Clinical Research Group for Gastroenterological Study. Tanaka K, et al. Surgery. 2014 Mar;155(3):424-31. doi: 10.1016/j.surg.2013.08.008. Epub 2013 Nov 25. Surgery. 2014. PMID: 24287145
Comparison of Billroth I and Roux-en-Y reconstruction after distal gastrectomy for gastric cancer: one-year postoperative effects assessed by a multi-institutional RCT.
Hirao M, Takiguchi S, Imamura H, Yamamoto K, Kurokawa Y, Fujita J, Kobayashi K, Kimura Y, Mori M, Doki Y; Osaka University Clinical Research Group for Gastroenterological Study. Hirao M, et al. Ann Surg Oncol. 2013 May;20(5):1591-7. doi: 10.1245/s10434-012-2704-9. Epub 2012 Oct 28. Ann Surg Oncol. 2013. PMID: 23104705 Clinical Trial.
A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer: results from a multi-institutional RCT.
Takiguchi S, Yamamoto K, Hirao M, Imamura H, Fujita J, Yano M, Kobayashi K, Kimura Y, Kurokawa Y, Mori M, Doki Y; Osaka University Clinical Research Group for Gastroenterological Study. Takiguchi S, et al. Gastric Cancer. 2012 Apr;15(2):198-205. doi: 10.1007/s10120-011-0098-1. Epub 2011 Oct 13. Gastric Cancer. 2012. PMID: 21993852 Clinical Trial.